Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Oesophageal Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02721563
What this trial is testing

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

Who this might be right for
Esophageal Neoplasms
Shandong Cancer Hospital and Institute 77
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814158
What this trial is testing

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Who this might be right for
Esophageal Squamour Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 57
Not applicableActive Not RecruitingNCT06762158
What this trial is testing

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
RenJi Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06764355
What this trial is testing

Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCCTotal Neoadjuvant TreatmentPathological Complete Response
National Taiwan University Hospital 50
Not applicableNot Yet RecruitingNCT07533357
What this trial is testing

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Fudan University 158
Testing effectiveness (Phase 2)Looking for participantsNCT06780111
What this trial is testing

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 298
Not applicableUnknownNCT05615103
What this trial is testing

The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Guangdong Provincial People's Hospital 100
Testing effectiveness (Phase 2)WithdrawnNCT02034968
What this trial is testing

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

Who this might be right for
Stage IV Esophageal Squamous Cell Carcinoma
Zhejiang University
Testing effectiveness (Phase 2)UnknownNCT05013697
What this trial is testing

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Who this might be right for
Esophageal Neoplasms
Henan Cancer Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Early research (Phase 1)Looking for participantsNCT03740256
What this trial is testing

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Who this might be right for
Bladder CancerHead and Neck Squamous Cell CarcinomaCancer of the Salivary Gland+7 more
Baylor College of Medicine 45
Testing effectiveness (Phase 2)Looking for participantsNCT07405151
What this trial is testing

A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

Who this might be right for
Oesophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 60
Testing effectiveness (Phase 2)UnknownNCT05490719
What this trial is testing

A Phase II Study of CRT Combined With QL1706 in ESCC Patients

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 39
Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Early research (Phase 1)Looking for participantsNCT05208762
What this trial is testing

PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of the Head and NeckEsophageal Squamous Cell Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer 714
Not applicableLooking for participantsNCT06602843
What this trial is testing

Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 70
Early research (Phase 1)Study completedNCT03914443
What this trial is testing

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
National Cancer Center, Japan 37
Testing effectiveness (Phase 2)UnknownNCT00003326
What this trial is testing

Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Theradex 100
Next Page